51st ICON Conference in Mumbai - 29th Nov - 1st Dec 2024
+91 022 46039298
icon@oncologyindia.org
Become a Member
Indian Cooperative Oncology Network
ICON TRUST
Home
About ICON
Constitution
ICON Highlights
Consent Form
Contact Us
Members
Become a Member
Download Application Form
Register Online
Member List
Committee
Managing Committee
Scientific Advisory Committee
Disease Committee
Ethics Committee
FCRA Receipt
80G Certificate
Links
National Cancer Links
International Cancer Links
Media
Gallery
Current Affairs
Protocols
Guide to Protocols
Active Protocol
Young ICON
FCRA Receipt
Home
Committee
FCRA Receipt
1-Apr-2013 to 31-Mar-2016
Date
Name
Amount
18-Oct-2013
EISAI Pharmaceuticals India
18,00,000
15-Jan-2014
BMS India
5,00,000
4-Feb-2014
Medpace ChemGenix
4,53,885
24-Mar-204
Sequoia Capital I
3,00,000
08-Dec-2014
American Society of Clinical Oncology
5,78,853
17-Mar-2015
Sequoia Capital I
3,45,000
31-Mar-2015
EISAI Pharmaceuticals India
50,000
31-Mar-2015
EISAI Pharmaceuticals India
30,000
16-Jun-2015
GLOBAL SEVA FUND
99,652
14-Aug-2015
Merck Specialities Pvt. Ltd.
11,76,000
10-Sep-2015
Reche India
49,00,000
19-Oct-2015
Novarties India
98,000
31-Dec-2015
European Society of Medical Oncology
3,92,100
25-Jan-2016
Eli Litty & Co India Pvt Ltd.
4,90,000
03-Feb-2016
Abbott Healthcare
5,00,000
05-Feb-2016
Merck Specialities Pvt. Ltd.
2,54,800
23-Mar-2016
Sequoia Capital I
9,00,000
28-Mar-2016
Boehringer Ingeltheim
9,80,000
28-Mar-2016
Boehringer Ingeltheim
1,47,000
Total
1,39,95,289